Association Study of Single-Nucleotide Polymorphism in Lymphotoxin Alpha Gene and Bipolar I Disorder

제1형 양극성 장애와 Lymphotoxin Alpha 유전자 단일염기 다형성 연관 연구

  • Kim, Sang-Ha (Department of Psychiatry, The Catholic University of Korea College of Medicine) ;
  • Jun, Tae-Youn (Department of Psychiatry, The Catholic University of Korea College of Medicine)
  • 김상하 (가톨릭대학교 의과대학 정신건강의학교실) ;
  • 전태연 (가톨릭대학교 의과대학 정신건강의학교실)
  • Received : 2012.03.13
  • Accepted : 2012.07.12
  • Published : 2012.08.31

Abstract

Objectives : Proinflammatory process has been implicated as an underlying mechanism of bipolar disorder and schizophrenia. Previous studies have suggested a possible role of lymphotoxin alpha (LTA) gene in the development of schizophrenia and have prompted further investigation in bipolar patients. Association of the LTA +252A/G polymorphism with susceptibility to bipolar I disorder itself as well as with vulnerability among a subset of psychotic bipolar patients were tested. Methods : DNA extraction was done by a standard method and genotyping was carried out by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method in 114 Korean patients with bipolar I disorder and 202 healthy controls. SPSS v18.0 was used for statistical analysis. Comparisons of the genotype and allele distributions in LTA +252A/G polymorphism were made using a chi-square test. The genotype and allele associations were also evaluated using odds ratio (OR) and 95% confidence interval (CI). Statistical significance was accepted when p was < 0.05. Results : No significant association was found between the LTA +252A/G polymorphism and bipolar disorder. However, LTA +252G allele was present with significantly higher frequency among bipolar patients with psychotic features compared to those without (${\chi}^2$ = 4.69, p = 0.034, OR = 2.495, 95% CI = 1.069-5.827). Conclusion : The results suggest that the allele LTA +252G of the polymorphism may be associated with the psychotic subset of bipolar disorder but not with bipolar I disorder itself. Adequately powered subsequent studies should be conducted.

Keywords

References

  1. McGuffin P, Rijsdijk F, Andrew M, Sham P, Katz R, Cardno A. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry 2003;60:497-502. https://doi.org/10.1001/archpsyc.60.5.497
  2. Craddock N, Jones I. Genetics of bipolar disorder. J Med Genet 1999;36:585-594. https://doi.org/10.1136/jmg.36.8.585
  3. Tsai SY, Chen KP, Yang YY, Chen CC, Lee JC, Singh VK, et al. Activation of indices of cell-mediated immunity in bipolar mania. Biol Psychiatry 1999;45:989-994. https://doi.org/10.1016/S0006-3223(98)00159-0
  4. Brietzke E, Stertz L, Fernandes BS, Kauer-Sant'anna M, Mascarenhas M, Escosteguy Vargas A, et al. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord 2009;116:214-217. https://doi.org/10.1016/j.jad.2008.12.001
  5. Kunz M, Cereser KM, Goi PD, Fries GR, Teixeira AL, Fernandes BS, et al. Serum levels of IL-6, IL-10 and TNF-${\alpha}$ in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance. Rev Bras Psiquiatr 2011;33:268-274.
  6. Denicoff KD, Rubinow DR, Papa MZ, Simpson C, Seipp CA, Lotze MT, et al. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann Intern Med 1987;107:293-300. https://doi.org/10.7326/0003-4819-107-2-293
  7. Boukhris W, Kouassi E, Revillard JP. Differential effect of mixed D1/D2 and selective D2 dopaminergic antagonists on mouse T and B lymphocyte proliferation and interleukin production in vitro. Immunopharmacol Immunotoxicol 1988;10:501-512. https://doi.org/10.3109/08923978809006451
  8. Messer G, Spengler U, Jung MC, Honold G, Blomer K, Pape GR, et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 1991;173:209-219. https://doi.org/10.1084/jem.173.1.209
  9. Cazzullo CL, Scarone S, Grassi B, Vismara C, Trabattoni D, Clerici M, et al. Cytokines production in chronic schizophrenia patients with or without paranoid behaviour. Prog Neuropsychopharmacol Biol Psychiatry 1998;22:947-957. https://doi.org/10.1016/S0278-5846(98)00059-1
  10. Cazzullo CL, Sacchetti E, Galluzzo A, Panariello A, Adorni A, Pegoraro M, et al. Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:33-39. https://doi.org/10.1016/S0278-5846(01)00221-4
  11. Pope HG Jr, Yurgelun-Todd D. Schizophrenic individuals with bipolar first-degree relatives: analysis of two pedigrees. J Clin Psychiatry 1990;51:97-101.
  12. Valles V, Van Os J, Guillamat R, Gutierrez B, Campillo M, Gento P, et al. Increased morbid risk for schizophrenia in families of in-patients with bipolar illness. Schizophr Res 2000;42:83-90. https://doi.org/10.1016/S0920-9964(99)00117-6
  13. Wildenauer DB, Schwab SG, Maier W, Detera-Wadleigh SD. Do schizophrenia and affective disorder share susceptibility genes? Schizophr Res 1999;39:107-111; discussion 160. https://doi.org/10.1016/S0920-9964(99)00108-5
  14. Berrettini W. Evidence for shared susceptibility in bipolar disorder and schizophrenia. Am J Med Genet C Semin Med Genet 2003;123C:59-64. https://doi.org/10.1002/ajmg.c.20014
  15. Craddock N, O'Donovan MC, Owen MJ. The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J Med Genet 2005;42:193-204. https://doi.org/10.1136/jmg.2005.030718
  16. Schulze TG, Buervenich S, Badner JA, Steele CJ, Detera-Wadleigh SD, Dick D, et al. Loci on chromosomes 6q and 6p interact to increase susceptibility to bipolar affective disorder in the national institute of mental health genetics initiative pedigrees. Biol Psychiatry 2004;56:18-23. https://doi.org/10.1016/j.biopsych.2004.04.004
  17. Cao Q, Martinez M, Zhang J, Sanders AR, Badner JA, Cravchik A, et al. Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees. Genomics 1997;43:1-8. https://doi.org/10.1006/geno.1997.4815
  18. Straub RE, MacLean CJ, O'Neill FA, Burke J, Murphy B, Duke F, et al. A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for genetic heterogeneity. Nat Genet 1995;11:287-293. https://doi.org/10.1038/ng1195-287
  19. Jun TY, Pae CU, Chae JH, Bahk WM, Kim KS, Han H, et al. TNFB polymorphism may be associated with schizophrenia in the Korean population. Schizophr Res 2003;61:39-45. https://doi.org/10.1016/S0920-9964(02)00303-1
  20. Shirts BH, Bamne M, Kim JJ, Talkowski M, Wood J, Yolken R, et al. A comprehensive genetic association and functional study of TNF in schizophrenia risk. Schizophr Res 2006;83:7-13. https://doi.org/10.1016/j.schres.2005.12.853
  21. Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Wagner RL, Yolken RH. Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav Immun 2001;15:411-420. https://doi.org/10.1006/brbi.2001.0644
  22. Sadock BJ, Sadock VA. Mood disorders. In: Sadock VA. Kaplan & Sadock's Synopsos of Psychiatry. 10th ed. Philadelphia, PA: Lippincott Williams & Wilkins, a Wolters Kluwer Business;2007. p.527-568.
  23. Mood disorders work group. Mood disorders. In: American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed., text revision. Washington, DC: American Psychiatric Association;2000. p.345-428.
  24. Park N, Juo SH, Cheng R, Liu J, Loth JE, Lilliston B, et al. Linkage analysis of psychosis in bipolar pedigrees suggests novel putative loci for bipolar disorder and shared susceptibility with schizophrenia. Mol Psychiatry 2004;9:1091-1099. https://doi.org/10.1038/sj.mp.4001541
  25. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215. https://doi.org/10.1093/nar/16.3.1215
  26. Keso T, Perola M, Laippala P, Ilveskoski E, Kunnas TA, Mikkelsson J, et al. Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men. Atherosclerosis 2001;154:691-697. https://doi.org/10.1016/S0021-9150(00)00602-X
  27. Ozaki K, Ohnishi Y, Iida A, Sekine A, Yamada R, Tsunoda T, et al. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002;32:650-654. https://doi.org/10.1038/ng1047
  28. Balding J, Kane D, Livingstone W, Mynett-Johnson L, Bresnihan B, Smith O, et al. Cytokine gene polymorphisms: association with psoriatic arthritis susceptibility and severity. Arthritis Rheum 2003;48:1408-1413. https://doi.org/10.1002/art.10935
  29. Knight JC, Keating BJ, Kwiatkowski DP. Allele-specific repression of lymphotoxin-alpha by activated B cell factor-1. Nat Genet 2004;36:394-399. https://doi.org/10.1038/ng1331
  30. Sestak AL, Nath SK, Sawalha AH, Harley JB. Current status of lupus genetics. Arthritis Res Ther 2007;9:210. https://doi.org/10.1186/ar2176
  31. Cheng B, Christakos S, Mattson MP. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 1994;12:139-153. https://doi.org/10.1016/0896-6273(94)90159-7
  32. Pearce BD. Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms. Mol Psychiatry 2001;6:634-646. https://doi.org/10.1038/sj.mp.4000956
  33. Dick DM, Foroud T, Flury L, Bowman ES, Miller MJ, Rau NL, et al. Genomewide linkage analyses of bipolar disorder: a new sample of 250 pedigrees from the National Institute of Mental Health Genetics Initiative. Am J Hum Genet 2003;73:107-114. https://doi.org/10.1086/376562
  34. Um JY, Kim HM. Frequencies of the tumor necrosis factor gene polymorphisms in the Korean population. Hereditas 2003;139:184-188.
  35. Garcia-Elorriaga G, Carrillo-Montes G, Mendoza-Aguilar M, Gonzalez- Bonilla C. Polymorphisms in tumor necrosis factor and lymphotoxin A in tuberculosis without and with response to treatment. Inflammation 2010;33:267-275. https://doi.org/10.1007/s10753-010-9181-8
  36. Whichelow CE, Hitman GA, Raafat I, Bottazzo GF, Sachs JA. The effect of TNF*B gene polymorphism on TNF-alpha and -beta secretion levels in patients with insulin-dependent diabetes mellitus and healthy controls. Eur J Immunogenet 1996;23:425-435. https://doi.org/10.1111/j.1744-313X.1996.tb00133.x
  37. Raybould R, Green EK, MacGregor S, Gordon-Smith K, Heron J, Hyde S, et al. Bipolar disorder and polymorphisms in the dysbindin gene (DTNBP1). Biol Psychiatry 2005;57:696-701. https://doi.org/10.1016/j.biopsych.2005.01.018
  38. Owen MJ, Craddock N, O'Donovan MC. Schizophrenia: genes at last? Trends Genet 2005;21:518-525. https://doi.org/10.1016/j.tig.2005.06.011
  39. Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT. Neurobiology of schizophrenia. Neuron 2006;52:139-153. https://doi.org/10.1016/j.neuron.2006.09.015
  40. Straub RE, Weinberger DR. Schizophrenia genes - famine to feast. Biol Psychiatry 2006;60:81-83. https://doi.org/10.1016/j.biopsych.2006.06.002
  41. Riley B, Kendler KS. Molecular genetic studies of schizophrenia. Eur J Hum Genet 2006;14:669-680. https://doi.org/10.1038/sj.ejhg.5201571
  42. Serretti A, Mandelli L. The genetics of bipolar disorder: genome 'hot regions,' genes, new potential candidates and future directions. Mol Psychiatry 2008;13:742-771. https://doi.org/10.1038/mp.2008.29
  43. Craddock N, Sklar P. Genetics of bipolar disorder: successful start to a long journey. Trends Genet 2009;25:99-105. https://doi.org/10.1016/j.tig.2008.12.002
  44. Prata DP, Breen G, Osborne S, Munro J, St Clair D, Collier DA. An association study of the neuregulin 1 gene, bipolar affective disorder and psychosis. Psychiatr Genet 2009;19:113-116. https://doi.org/10.1097/YPG.0b013e32832a4f69